Ushiku, Japan

Tsutomu Kobayashi

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsutomu Kobayashi. Retrieved from https://idiyas.com/inventor/tsutomu-kobayashi-fsxlsf8d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tsutomu Kobayashi: Innovator in Obesity Treatment

Introduction

Tsutomu Kobayashi is a notable inventor based in Ushiku, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of obesity. His innovative approach has led to the development of a unique method for evaluating compounds that may be effective in treating obesity.

Latest Patents

Kobayashi holds a patent for a method of evaluating compounds efficacious in treating obesity. This patent involves the examination of obesity or emaciation based on the expression levels of the LCE gene or protein in a test tissue or cell. The evaluation of compounds includes the screening of therapeutic agents for obesity or emaciation, utilizing the characteristics of the LCE gene or protein. He has 1 patent to his name.

Career Highlights

Tsutomu Kobayashi is associated with Banyu Pharmaceutical Co. Ltd., where he applies his expertise in research and development. His work focuses on innovative solutions to combat obesity, a growing health concern worldwide.

Collaborations

Kobayashi has collaborated with notable colleagues, including Nao Odagiri and Hiroaki Suwa. Their combined efforts contribute to advancing research in obesity treatment.

Conclusion

Tsutomu Kobayashi's work in evaluating compounds for obesity treatment showcases his dedication to medical innovation. His contributions are vital in the ongoing battle against obesity, highlighting the importance of research in developing effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…